Acetylsalicylic acid
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
Anopyrin contains acetylsalicylic acid, which in small doses belongs to a group of medicines called antiplatelet agents. Platelets are small cells that cause blood clots to form and participate in the formation of thrombosis. When a clot forms in an artery, it blocks blood flow and cuts off oxygen supply. If this happens in the heart, it can cause a heart attack or angina pectoris; in the brain, it can cause a stroke.
Anopyrin is used to reduce the risk of blood clots, and thus prevent subsequent:
Anopyrin is also used to prevent blood clots after certain cardio-surgical procedures performed to widen or unblock blood vessels.
This medicine is not recommended for use in situations requiring emergency assistance.
Before taking Anopyrin, the patient should discuss with their doctor if:
In case of worsening symptoms or severe or unexpected side effects, such as unusual bleeding, severe skin reactions, or any symptoms of severe allergic reactions, the patient should seek medical help immediately (see section 4 "Possible side effects").
The patient should inform their doctor before planned surgery (even minor, e.g., tooth extraction), as acetylsalicylic acid thins the blood and may increase the risk of bleeding.
The patient should not become dehydrated (may feel thirsty and dry mouth), as taking acetylsalicylic acid may cause kidney problems.
This medicine is not suitable for relieving pain or reducing fever.
If any of these situations apply to the patient, they should consult their doctor or pharmacist.
Acetylsalicylic acid may cause Reye's syndrome in children. Reye's syndrome is a very rare disease that affects the brain and liver and can be life-threatening. Therefore, Anopyrin should not be given to children under 16 years of age, unless advised by a doctor.
The patient should tell their doctor or pharmacist about all medicines they are taking, have recently taken, or plan to take.
Taking acetylsalicylic acid with certain other medicines may affect the treatment effect. These include medicines used:
Drinking alcohol may increase the risk of gastrointestinal bleeding and prolong bleeding time.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Women who are pregnant should not take acetylsalicylic acid unless advised by a doctor.
Anopyrin should not be taken during the last 3 months of pregnancy, unless advised by a doctor, and the daily dose should not exceed 100 mg (see section "When not to take Anopyrin"). Regular intake of this medicine or high doses in late pregnancy may cause serious complications in the mother or child.
Women who are breastfeeding should not take acetylsalicylic acid unless advised by a doctor.
Acetylsalicylic acid may affect female fertility by affecting ovulation. This effect is reversible after stopping treatment.
Anopyrin is unlikely to affect the ability to drive or use machines.
If the patient has been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
Orange yellow may cause allergic reactions.
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
Adults
Prevention of heart attack:
Prevention of strokes:
Prevention of cardiovascular diseases in patients with stable or unstable angina pectoris (a type of chest pain):
Prevention of blood clots after certain heart surgeries:
The medicine should not be taken in higher doses unless advised by a doctor. The dose should not exceed 300 mg per day.
Elderly
The recommended dose is the same as for adults. However, elderly patients should take acetylsalicylic acid with caution due to the increased risk of side effects. The treatment should be regularly discussed with the doctor.
Children and adolescents
Acetylsalicylic acid should not be given to children and adolescents under 16 years of age unless advised by a doctor (see section "Warnings and precautions").
Method of administration
Oral use.
The tablets should be swallowed whole with a sufficient amount of liquid (1/2 glass of water). The tablets have a coating that protects them from stomach acid, which prevents irritating effects on the intestine, and therefore they should not be crushed, broken, or chewed.
If the patient (or someone else) has taken too many tablets, they should immediately contact a doctor or the nearest hospital emergency department. The patient should show the doctor the remaining tablets or the empty packaging of the medicine.
Symptoms of overdose may include: ringing in the ears, hearing disturbances, headache, dizziness, confusion, nausea, vomiting, and abdominal pain. Significant overdose may cause rapid breathing (hyperventilation), fever, excessive sweating, restlessness, seizures, hallucinations, low blood sugar, pulmonary edema, coma, and shock.
If the patient forgets to take a dose, they should wait until the next dose is due and then continue taking the medicine as usual. The patient should not take a double dose to make up for the missed dose.
The patient should not stop taking Anopyrin without first discussing it with their doctor.
If the patient has any further questions about the use of this medicine, they should consult their doctor or pharmacist.
Like all medicines, Anopyrin can cause side effects, although not everybody gets them.
Redness of the skin with blistering or peeling, may be accompanied by high fever and joint pain. This may be erythema multiforme, Stevens-Johnson syndrome, or Lyell's syndrome.
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Frequency not known (frequency cannot be estimated from the available data):
If the patient experiences any side effects, including any possible side effects not listed in this leaflet, they should inform their doctor, pharmacist, or nurse.
Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Poland, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder or its representative.
Reporting side effects will help to gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not store above 25°C. Store in the original packaging to protect from light.
Do not use this medicine after the expiry date stated on the carton or blister after EXP.
The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines no longer required.
This will help protect the environment.
Pink, round, biconvex, film-coated tablet with a diameter of approximately 7.2 mm.
Pack sizes
60 enteric-coated tablets.
Not all pack sizes may be marketed.
Zentiva, k.s., U kabelovny 130, Dolní Měcholupy, 102 37 Prague 10, Czech Republic
Denmark, Poland: Anopyrin
Zentiva Polska Sp. z o.o., ul. Bonifraterska 17, 00-203 Warsaw, Poland, tel.: +48 22 375 92 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.